Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 236 (8%)
Anticipated shortage: 18 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

29 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-OXYCODONE CR 20.0MG TABLET (EXTENDED-RELEASE) Resolved 2017-10-11 2018-03-13 25304
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-07 2018-01-18 28534
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-07 2018-01-10 28553
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-21 2018-03-21 29960
APO-DICLO SR 75MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-27 2018-04-17 30805
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-28 2018-01-22 31039
APO-OXYCODONE CR 40MG TABLET (EXTENDED-RELEASE) Resolved 2017-12-20 2018-03-21 33867
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2018-01-22 2018-06-12 36817
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-01-31 2018-05-05 37732
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-05-24 37963
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-06-04 37966
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-06 2018-07-03 38815
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-13 2018-07-03 39659
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-21 2018-03-08 40336
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2018-03-27 2018-07-03 44102
APO-ISMN 60MG TABLET (EXTENDED-RELEASE) Resolved 2018-05-22 2018-08-09 50044
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-04 2018-08-01 54285
APO-DICLO SR 100MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-11 2020-01-07 55264
APO-DICLO SR 75MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-11 2020-01-07 55267
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-11 2018-08-01 55299

Showing 81 to 100 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110968
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110971
APO-HYDROMORPHONE CR 4.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110974
APO-HYDROMORPHONE CR 9MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110977
APO-DILTIAZ CD 300MG CAPSULE (CONTROLLED-DELIVERY) Discontinued 2019-02-01 2019-02-02 74366
APO-NIZATIDINE 150MG CAPSULE Discontinued 2017-03-13 2017-03-13 1127
APO-NIZATIDINE 300MG CAPSULE Discontinued 2017-03-13 2017-03-13 1135
APO-NORTRIPTYLINE 10MG CAPSULE Discontinued 2017-03-13 2017-03-13 1145
APO-NORTRIPTYLINE 25MG CAPSULE Discontinued 2017-03-13 2017-03-13 1155
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-DOCUSATE SODIUM 100MG CAPSULE Discontinued 2018-02-23 2019-03-29 40733
DOCUSATE SODIUM CAPSULES 100MG CAPSULE Discontinued 2018-02-23 2018-09-15 40738
APO-AMOXI 250MG CAPSULE Discontinued 2018-09-07 2019-02-13 60171
APO-AMOXI 500MG CAPSULE Discontinued 2018-09-07 2018-11-09 60174
APO-ATOMOXETINE 60MG CAPSULE Discontinued 2018-09-07 2018-09-15 60273
APO-CELECOXIB 100MG CAPSULE To be discontinued 2018-09-07 2018-12-11 60363
APO-CELECOXIB 200MG CAPSULE Discontinued 2018-09-07 2021-01-21 60366
APO-CLINDAMYCIN 150MG CAPSULE To be discontinued 2018-09-07 2018-12-28 60396
APO-CLINDAMYCIN 300MG CAPSULE Discontinued 2018-09-07 2019-07-13 60399
APO-DOXY CAP 100MG 100MG CAPSULE Discontinued 2018-09-07 2018-09-29 60459

Showing 281 to 300 of 356